Close X

Attorney Spotlight

How does Eli Richardson's past work with the federal government inform his client interactions? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2016, AmSurg Corp. and Envision Healthcare Holdings, Inc. (Envision) announced they have signed a definitive merger agreement pursuant to which the companies will combine in an all-stock transaction. Upon completion of the merger, which is expected to be tax-free to the shareholders of both organizations, the combined company will be named Envision Healthcare Corporation and co-headquartered in Nashville, Tennessee and Greenwood Village, Colorado. The company's common stock is expected to trade on the New York Stock Exchange under the ticker symbol: EVHC. Bass, Berry & Sims served as lead counsel on the transaction, led by Jim Jenkins. Read more.

AmSurg logo


Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Inside the FCA blogInside the FCA blog features ongoing updates related to the False Claims Act (FCA), including insight on the latest legal decisions, regulatory developments and FCA settlements. The blog provides timely updates for corporate boards, directors, compliance managers, general counsel and other parties interested in the organizational impact and legal developments stemming from issues potentially giving rise to FCA liability.

Read More >

J. Allen Overby

Member

Nashville
(615) 742-6211 TEL
(615) 742-2711 FAX

J. Allen Overby

Member

Nashville
(615) 742-6211 TEL
(615) 742-2711 FAX
Nashville
(615) 742-6211 TEL
(615) 742-2711 FAX

Allen Overby has counseled some of the nation's most influential companies with respect to mergers and acquisitions, corporate governance, public company disclosure obligations, and a wide range of securities regulation matters. Allen's practice focuses primarily on public companies and middle market M&A transactions between $50 million and $1 billion, with an emphasis on cross border mergers and acquisitions and other strategic transactions.

Allen has been recognized by Chambers USA as "'a top-flight attorney - incredibly responsive and creative, a real problem solver.'" (from Chambers USA 2016).

Allen Overby has counseled some of the nation's most influential companies with respect to mergers and acquisitions, corporate governance, public company disclosure obligations, and a wide range of securities regulation matters. Allen's practice focuses primarily on public companies and middle market M&A transactions between $50 million and $1 billion, with an emphasis on cross border mergers and acquisitions and other strategic transactions.

Allen has been recognized by Chambers USA as "'a top-flight attorney - incredibly responsive and creative, a real problem solver.'" (from Chambers USA 2016). Allen's practice involves:

  • Mergers & Acquisitions/Cross-Border & Domestic – Representing public and private companies in connection with merger and acquisition transactions, and financing transactions (including offerings of debt and equity securities); Representing companies based in the U.S. and abroad in connection with cross-border mergers and acquisitions and strategic investments.
  • Corporate Governance & Public Company Disclosure – Advising public companies on corporate governance, fiduciary duties, securities law compliance, public company disclosure obligations, executive compensation and takeover defense matters.
  • Securities Regulation – Advising as independent counsel for regulatory and compliance matters. Representative matters include the Regulatory Audit of the New York Stock Exchange from 2005 to 2013 and serving as audit committee disclosure counsel to an NYSE listed global financial services company. As a former member of the staff of the Division of Enforcement at the U.S. Securities and Exchange Commission (SEC) in Washington, D.C., Allen also works closely with audit and special committees regarding a wide variety of issues.

Allen is a past member of the firm's Executive Committee and currently serves as the chair of the Corporate & Securities Practice Group.

In addition to his law practice, Allen serves as an adjunct professor at the Vanderbilt University Law School where he has taught courses on mergers and acquisitions and the federal securities laws.

+ Read More

- Read Less

Memberships

American Health Lawyers Association (AHLA)

Lex Mundi — Cross Border Transactions Group

News

View More

Representative Experience

View More

Publications

View More

Upcoming Events

Past Events

View More

Media Mentions

View More

Accolades

Chambers USA — Corporate M&A (2008-2009, 2013-2016)

Best Lawyers in America® — Corporate Governance Law; Corporate Law; Leveraged Buyouts and Private Equity Law; Mergers and Acquisitions Law; Securities Regulation (2007-2017)

Best Lawyers in America®  — Nashville Leveraged Buyouts and Private Equity Law "Lawyer of the Year"(2017); Nashville Securities Regulation "Lawyer of the Year" (2014); Nashville Mergers and Acquisitions Law "Lawyer of the Year" (2012)

The Legal 500 United States 2016 — M&A/Corporate and Commercial for M&A: Middle-Market (sub-$500m)

Lawdragon "New Stars"

Mid-South Super Lawyers (2007-2008)

Mississippi Law Journal — Editorial Board Member (1987)

U.S. Securities and Exchange Commission — Former Senior Counsel

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.